<DOC>
	<DOCNO>NCT01364961</DOCNO>
	<brief_summary>Although much effort do low LDL-cholesterol concentration , still substantial risk cardiovascular disease ( CVD ) . Another strategy low risk CVD elevate HDL-cholesterol ( HDL-C ) . Both vitro vivo study show elevate HDL-C apolipoprotein A-I ( Apo A-I ) level protect CVD . However , despite many initiative , new widely applicable intervention strategy prove efficacy develop . Epidemiologic study show high polyphenol intake associate low risk CVD . Resveratrol , polyphenol , could , several beneficial mechanism , exert positive effect formation atherosclerotic plaque thus develop CVD . It show animal resveratrol elevate PPAR-alpha activity . This may lead elevated apo A-I HDL-C level blood . However , effect show human intervention study .</brief_summary>
	<brief_title>Resveratrol Serum Apo A-I</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>age 45 70 year HDLC &lt; 1.0 mmol/L ( men ) HDLC &lt; 1.3 mmol/L ( woman ) serum total cholesterol &lt; 8.0 mmol/L plasma glucose &lt; 7.0 mmol/L BMI 25 35 kg/m2 nonsmoking willingness abstain resveratrol rich product two week prior study duration study : grape grape juice wine ( red white ) berry peanuts peanut butter soy ( product ) pomegranate unstable body weight ( weight gain loss &gt; 3 kg past 3 month ) indication treatment cholesterollowering drug accord Dutch Cholesterol Consensus use medication medicallyprescribed diet know affect serum lipid glucose metabolism Active cardiovascular disease ( instance congestive heart failure ) recent ( &lt; 6 month ) event , acute myocardial infarction cerebrovascular accident willing stop consumption vitamin supplement , fish oil capsule product rich plant stanol sterol esters 3 week start study men : consumption &gt; 21 glass alcoholcontaining drink per week woman : consumption &gt; 14 glass alcoholcontaining drink per week abuse drug pregnant breastfeed woman participation another biomedical study within 1 month prior screen visit donate blood ( blood donor ) within 1 month prior screen visit planning study impossible difficult puncture evidence screen visit</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Resveratrol</keyword>
	<keyword>FMD</keyword>
	<keyword>PWV</keyword>
	<keyword>HDL-cholesterol</keyword>
	<keyword>Macrovasculature</keyword>
	<keyword>Microvasculature</keyword>
</DOC>